Literature DB >> 21487942

Chronological change of antibiotic use and antibiotic resistance in Escherichia coli causing urinary tract infections.

Katsumi Shigemura1, Kazushi Tanaka, Masayo Adachi, Masuo Yamashita, Soichi Arakawa, Masato Fujisawa.   

Abstract

Overuse of antibiotics can cause the emergence of resistant bacterial strains. This study retrospectively investigated recent trends in Escherichia coli causing urinary tract infections (UTIs), focusing on antibiotic use and antibiotic susceptibilities. Patients diagnosed with UTIs caused by E. coli in Akashi Municipal Hospital between April 2004 and March 2010 were enrolled in the study. A total of 858 UTI cases were examined. Antibiotics used in our hospital during that period and the antibiotic susceptibilities of E. coli in UTI cases were assessed. We analyzed the data on a yearly basis, with the year being defined as the period from April to the following March (e.g., in this study the period from April 2004 to March 2005 represents 2004). The first 3 years (2004-2006) were compared to the last 3 years (2007-2009). The use of piperacillin, cephazolin, amikacin, oral cefotiam, and levofloxacin decreased significantly and the use of imipenem, gentamicin (GM), cefcapene, and oral minocycline (MINO) increased significantly in the last 3 years compared to the previous 3 years. The susceptibilities of MINO in complicated cystitis significantly increased and those of GM in uncomplicated pyelonephritis significantly decreased in these 3 years (2007-2009) compared to the previous 3 years (2004-2006) (P < 0.05). Additionally, extended-spectrum β-lactamase (ESBL)-producing E. coli tended to be isolated more often; this was statistically significant in the last 3 years (2007-2009) compared to the previous 3 years (2004-2006) (P < 0.05). In conclusion, we found changes in our pattern of antibiotic use associated with changes in antibiotic susceptibilities and an increase in ESBL-producing E. coli isolated from our UTI cases. Monitoring of antibiotic use and emergence of resistant strains should be continued.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21487942     DOI: 10.1007/s10156-011-0241-2

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  11 in total

1.  Shock due to urosepsis: A multicentre study.

Authors:  Fukashi Yamamichi; Katsumi Shigemura; Koichi Kitagawa; Kei Takaba; Issei Tokimatsu; Soichi Arakawa; Masato Fujisawa
Journal:  Can Urol Assoc J       Date:  2017-03-16       Impact factor: 1.862

2.  Evaluating biological plausibility in supporting evidence for action through systematic reviews in public health.

Authors:  J Dailey; L Rosman; E K Silbergeld
Journal:  Public Health       Date:  2018-10-25       Impact factor: 2.427

3.  Antibiograms from community-acquired uropathogens in Gulu, northern Uganda--a cross-sectional study.

Authors:  Charles O Odongo; Denis A Anywar; Kenneth Luryamamoi; Pancras Odongo
Journal:  BMC Infect Dis       Date:  2013-04-29       Impact factor: 3.090

4.  Clinical impact of bacterial contamination of perfusion fluid in kidney transplantation.

Authors:  A Ranghino; D Diena; F Simonato; M Messina; M Burdese; V Piraina; F Fop; G P Segoloni; L Biancone
Journal:  Springerplus       Date:  2016-01-04

5.  Surgical and functional outcomes of radical retropubic prostatectomy after biopsy-related acute prostatitis.

Authors:  Şükrü Kumsar; Emre Karabay; Omer Yüksel; Feridun Şengör
Journal:  Cent European J Urol       Date:  2019-01-22

6.  Prophylactic antibiotic regimens in tumour surgery (PARITY): protocol for a multicentre randomised controlled study.

Authors:  Michelle Ghert; Benjamin Deheshi; Ginger Holt; R Lor Randall; Peter Ferguson; Jay Wunder; Robert Turcotte; Joel Werier; Paul Clarkson; Timothy Damron; Joseph Benevenia; Megan Anderson; Mark Gebhardt; Marc Isler; Sophie Mottard; John Healey; Nathan Evaniew; Antonella Racano; Sheila Sprague; Marilyn Swinton; Dianne Bryant; Lehana Thabane; Gordon Guyatt; Mohit Bhandari
Journal:  BMJ Open       Date:  2012-11-28       Impact factor: 2.692

7.  Multidrug resistance and extended-spectrum β-lactamases genes among Escherichia coli from patients with urinary tract infections in Northwestern Libya.

Authors:  Abubaker A Abujnah; Abdulaziz Zorgani; Mohamed A M Sabri; Hanan El-Mohammady; Rania A Khalek; Khalifa S Ghenghesh
Journal:  Libyan J Med       Date:  2015-02-02       Impact factor: 1.743

8.  Evaluation of antibiotic susceptibility test results: how guilty a laboratory could be?

Authors:  Mohamed S M Nassar; Walaa A Hazzah; Wafaa M K Bakr
Journal:  J Egypt Public Health Assoc       Date:  2019-01-11

9.  Escherichia coli Resistance to Fluoroquinolones in Community-Acquired Uncomplicated Urinary Tract Infection in Women: a Systematic Review.

Authors:  Ann E Stapleton; Florian M E Wagenlehner; Aruni Mulgirigama; Monique Twynholm
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

10.  Phenotypic and Molecular Characterization of β-Lactamases among Enterobacterial Uropathogens in Southeastern Nigeria.

Authors:  M C Ugwu; M Shariff; C M Nnajide; K Beri; U M Okezie; I R Iroha; C O Esimone
Journal:  Can J Infect Dis Med Microbiol       Date:  2020-02-24       Impact factor: 2.585

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.